Monday, 12 November 2018

Nestle raises stake in food allergy drug developer Aimmune

The health science unit of Nestle SA would pay $98 million to increase its stake in Aimmune Therapeutics Inc, the drug developer for food allergies said on Monday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)